EP3190127
USE OF AN ANTIBODY DIRECTED AGAINST BDCA-2 FOR THE TREATMENT OF AUTOIMMUNE OR INFLAMMATORY DISORDERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.12.2011EP published:
7.10.2020EP application number:
17159253.8
EPO information:
European Patent Register
Max expiry date:
11.12.2031
Title:
USE OF AN ANTIBODY DIRECTED AGAINST BDCA-2 FOR THE TREATMENT OF AUTOIMMUNE OR INFLAMMATORY DISORDERS
Timeline
Today
12.12.2011EP application
7.10.2020EP Publication
Owner
Name:
Laboratoire Français du Fractionnement et des BiotechnologiesAddress:
ZA de Courtaboeuf 3, avenue des Tropiques, 91940 Les Ulis, FR
Inventor
Name:
FOURNIER, NathalieAddress:
59193 Erquinghem-Lys, FR
Name:
DE ROMEUF, ChristopheAddress:
59130 Lambersart, FR
Priority
Number:
1060428Date:
13.12.2010Country:
FR
Classification
Categories:
C07K 16/28, A61K 39/395, A61P 35/00, A61P 37/00